Torsten Malmström
Direttore Tecnico/Scientifico/R&S presso CAMURUS AB
Patrimonio netto: 3 M $ in data 30/06/2024
Posizioni attive di Torsten Malmström
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| CAMURUS AB | Direttore Tecnico/Scientifico/R&S | 01/01/2013 | - |
Storia della carriera di Torsten Malmström
Precedenti posizioni note di Torsten Malmström
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| ZEALAND PHARMA A/S | Corporate Officer/Principal | - | - |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Corporate Officer/Principal | - | - |
PolyPeptide Laboratories (Sweden) AB
 PolyPeptide Laboratories (Sweden) AB BiotechnologyHealth Technology PolyPeptide Laboratories (Sweden) AB specializes in the production of proprietary peptides. The firm manufactures polypeptide, custom peptide Synthesis, peptide synthesis, and generic peptide. Its peptides products are part of several different pharmaceutical products. The company was founded in 1996 and is headquartered in Malmo, Sweden. | Corporate Officer/Principal | - | - |
Formazione di Torsten Malmström
| University of Lund | Doctorate Degree |
Statistiche
Distribuzione geografica
| Svezia | 5 |
| Danimarca | 2 |
Posizioni
| Corporate Officer/Principal | 3 |
| Chief Tech/Sci/R&D Officer | 1 |
| Doctorate Degree | 1 |
Settori
| Health Technology | 4 |
| Consumer Services | 2 |
| Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| CAMURUS AB | Health Technology |
| ZEALAND PHARMA A/S | Health Technology |
| Aziende private | 2 |
|---|---|
PolyPeptide Laboratories (Sweden) AB
PolyPeptide Laboratories (Sweden) AB BiotechnologyHealth Technology PolyPeptide Laboratories (Sweden) AB specializes in the production of proprietary peptides. The firm manufactures polypeptide, custom peptide Synthesis, peptide synthesis, and generic peptide. Its peptides products are part of several different pharmaceutical products. The company was founded in 1996 and is headquartered in Malmo, Sweden. | Health Technology |
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Commercial Services |
- Borsa valori
- Insiders
- Torsten Malmström
- Esperienza
